Medacta International SA
medacta.comTotal trials
45
Active
28
Phase 3
0
Total enrollment
8,772
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Avascular Necrosis10
- Congenital Hip Dysplasia7
- Traumatic Arthritis7
- Arthritis6
- Osteoarthritis4
- Primary Osteoarthritis4
- Secondary Osteoarthritis4
- Total Hip Arthroplasty4
Frequently asked questions about Medacta International SA
- How many clinical trials does Medacta International SA have on ClinicalTrials.gov?
- Medacta International SA is listed as the lead sponsor on 45 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medacta International SA's trials are in Phase 3?
- 0 of Medacta International SA's trials are in Phase 3.
- What therapeutic areas does Medacta International SA focus on?
- Medacta International SA's most-studied conditions on ClinicalTrials.gov are Avascular Necrosis, Congenital Hip Dysplasia, Traumatic Arthritis, Arthritis, Osteoarthritis.